Literature DB >> 6114307

5-Aminosalicylic acid, a co-factor for colonic prostacyclin synthesis?

J R Hoult, H Page.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6114307     DOI: 10.1016/s0140-6736(81)90502-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Sulfasalazine. Multiplicity of action.

Authors:  T S Gaginella; R E Walsh
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

Review 2.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

Review 3.  Role of neutrophil-derived oxidants in the pathogenesis of intestinal inflammation.

Authors:  T Yamada; M B Grisham
Journal:  Klin Wochenschr       Date:  1991-12-15

4.  Prostanoids as friends, not foes: further evidence from the interference by cycloxygenase-inhibitory drugs when inducing tolerance to experimental arthritigens in rats.

Authors:  Michael W Whitehouse
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

Review 5.  Prostaglandins and ulcerative colitis.

Authors:  D S Rampton; C J Hawkey
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

6.  Inhibition of red cell membrane lipid peroxidation by sulphasalazine and 5-aminosalicylic acid.

Authors:  S M Greenfield; N A Punchard; R P Thompson
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

7.  Soybean lipoxygenase inhibition: studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine.

Authors:  H Allgayer; J Eisenburg; G Paumgartner
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Modulation of human colonic arachidonic acid metabolism by sulfasalazine.

Authors:  C J Hawkey; N K Boughton-Smith; B J Whittle
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

9.  Ulcerative colitis: effect of sulphasalazine, its metabolites and indomethacin on the ability of human colonic mucosa to metabolize prostaglandins in vitro.

Authors:  K Hillier; P J Mason; S Pacheco; C L Smith
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

10.  Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.

Authors:  K Lauritsen; J Hansen; P Bytzer; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.